Mitotherapeutix, LLC
Biotechnology company · Woodbridge, Connecticut, United States
Mitotherapeutix, LLC is a biotechnology company headquartered in Woodbridge, Connecticut, United States. Its earliest recorded incorporation is in 2014. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $3 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2025.
Mitotherapeutix at a glance
What does Mitotherapeutix do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $3 million in total (2017 to 2023). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Alcohol Abuse and Alcoholism.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3 million sold (2025).
Frequently asked questions about Mitotherapeutix
Where is Mitotherapeutix headquartered?
Mitotherapeutix, LLC is headquartered in Woodbridge, Connecticut, United States.
What does Mitotherapeutix do?
Mitotherapeutix, LLC is a biotechnology company.
When was Mitotherapeutix founded?
The earliest incorporation on record for Mitotherapeutix, LLC is in 2014, according to public company registers.
Similar companies
- Soterix Medical, Inc.Woodbridge, New Jersey, United States
- Myofinity Biosciences IncWoodbridge, Connecticut, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences